Cullinan Therapeutics Inc (CGEM)
EBITDA Growth
23.37%
Quarterly · Period ending:
CGEM EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported23.37%period ending
Latest reported23.37%period ending
CGEM Quarterly EBITDA YoY % (-7.28% → 23.37%)
Year-over-year change
High-resolution chart · PNG
CGEM ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 23.3688% | |
| -10.7238% | |
| -6.7035% | |
| -24.8172% | |
| -66.8089% | |
| -29.9512% | |
| -19.8066% | |
| 9.4783% | |
| -30.5543% | |
| 35.8281% | |
| -37.1136% | |
| -63.1988% | |
| 13.3741% | |
| -78.9657% | |
| 15.5203% | |
| -50.1918% | |
| -125.8249% | |
| -2,439.3655% | |
| -17.2714% | |
| -58.8819% | |
| -16.4469% | |
| 125.1041% | |
| -487.626% | |
| -65.5471% | |
| -173.9029% | |
| -7.2816% |